Global Osteoarthritis Therapeutics Market 2021

January 2022 | 14 pages | ID: G43051D893A2EN
StrategyHelix Inc

Abstracts

Arthritis refers to biomechanical changes within a joint. Osteoarthritis (OA) is the most common form of arthritis. It occurs most frequently in the hands, hips, and knees. A study by StrategyHelix indicates that the global osteoarthritis therapeutics market is expected to increase by US$ 3,358 million from 2021 to 2027, garnering a CAGR of 6.7% during the forecast period.

The report provides up-to-date market size data for period 2017-2020 and forecast to 2027 covering key market aspects like sales value for osteoarthritis therapeutics. The global osteoarthritis therapeutics market is segmented on the basis of anatomy, drug, drug classification, and region. Based on anatomy, the global osteoarthritis therapeutics market is categorized into knee osteoarthritis, hip osteoarthritis, others. Globally, the knee osteoarthritis segment made up the largest share of the osteoarthritis therapeutics market. On the basis of drug, the global osteoarthritis therapeutics market has been segmented into viscosupplementation agents, non-steroidal anti-inflammatory drugs (NSAIDs), analgesics, corticosteroids. By drug classification, the global osteoarthritis therapeutics market has been segmented into prescription drugs, OTC. In terms of geography, the global osteoarthritis therapeutics market has been segmented into Asia Pacific, Europe, North America, Rest of the World (RoW).

The global osteoarthritis therapeutics market is highly competitive. Some of the leading companies operating in the market are Abbott Laboratories, Anika Therapeutics Inc., Bayer AG, Bioventus Inc., Eli Lilly and Company, Ferring B.V., Fidia Farmaceutici S.p.A., Flexion Therapeutics Inc., GlaxoSmithKline plc, Horizon Therapeutics plc, Johnson & Johnson, Novartis International AG, Pfizer Inc., Sanofi S.A., Seikagaku Corporation.

Report Scope
Anatomy: knee osteoarthritis, hip osteoarthritis, others
Drug: viscosupplementation agents, non-steroidal anti-inflammatory drugs (NSAIDs), analgesics, corticosteroids
Drug classification: prescription drugs, OTC
Region: Asia Pacific, Europe, North America, Rest of the World (RoW)
Years considered: this report covers the period 2017 to 2027

Key Benefits for Stakeholders
Get a comprehensive picture of the global osteoarthritis therapeutics market
Pinpoint growth sectors and trends for investment

Contents

PART 1. INTRODUCTION

Scope of the study
Study period
Geographical scope
Research methodology

PART 2. OSTEOARTHRITIS THERAPEUTICS MARKET OVERVIEW

PART 3. MARKET BREAKDOWN BY ANATOMY

Knee osteoarthritis
Hip osteoarthritis
Others

PART 4. MARKET BREAKDOWN BY DRUG

Viscosupplementation agents
Non-steroidal anti-inflammatory drugs (NSAIDs)
Analgesics
Corticosteroids

PART 5. MARKET BREAKDOWN BY DRUG CLASSIFICATION

Prescription drugs
OTC

PART 6. MARKET BREAKDOWN BY REGION

Asia Pacific
Europe
North America
Rest of the World (RoW)

PART 7. KEY COMPANIES

Abbott Laboratories
Anika Therapeutics Inc.
Bayer AG
Bioventus Inc.
Eli Lilly and Company
Ferring B.V.
Fidia Farmaceutici S.p.A.
Flexion Therapeutics, Inc.
GlaxoSmithKline plc
Horizon Therapeutics plc
Johnson & Johnson
Novartis International AG
Pfizer Inc.
Sanofi S.A.
Seikagaku Corporation
About StrategyHelix
Disclaimer